
Women's Scalp Solution
The Women’s Scalp Solution is a targeted topical formula designed to address female pattern hair loss, diffuse thinning, and hormonal or stress-related shedding. It combines multiple active ingredients that work together at the scalp level without significant systemic absorption.
​
Key Ingredients and How They Work
-
Azelaic Acid (1 mg/mL) A naturally occurring dicarboxylic acid that inhibits 5-alpha-reductase locally, reducing DHT production in the scalp. It also calms inflammation, balances scalp microbiome, and provides antioxidant protection.
-
Estradiol (0.1 mg/mL) Bioidentical estrogen that binds to receptors in hair follicles, promoting the anagen (growth) phase, counteracting androgenic effects, and helping restore thickness and density—especially beneficial during perimenopause or postmenopause when estrogen declines.
-
Progesterone (10 mg/mL) Bioidentical progestogen that opposes androgen activity by inhibiting 5-alpha-reductase and DHT formation at the follicular level. It reduces inflammation, supports scalp barrier integrity, and protects against fibrosis.
-
Liothyronine (T3, 1 mcg/mL) Active thyroid hormone applied topically to enhance local metabolism in hair follicles, increase mitochondrial energy production, and promote anagen phase entry—addressing subclinical thyroid-related thinning or metabolic slowdown without significant systemic effects.
Combined Effect These ingredients work synergistically to combat androgen-driven miniaturization, support hormonal equilibrium at the scalp, reduce inflammation and oxidative stress, and boost follicular metabolism. The result is targeted, non-systemic support for hair regrowth and maintenance.
​
Potential Benefits
Women commonly use this solution for:
-
Female pattern hair loss (androgenic alopecia)
-
Diffuse thinning or widening part lines
-
Perimenopausal or postmenopausal shedding, dryness, and reduced density due to estrogen and progesterone decline
-
Telogen effluvium or thinning linked to stress, thyroid issues, or metabolic factors
-
Maintenance after initial stabilization with other hormone or metabolic therapies
Many women notice reduced shedding within 4–8 weeks, with visible improvements in thickness, density, and overall scalp health building over 3–6 months of consistent twice-daily application.
